Search Results
OPTIMAL: bortezomib-based therapy vs thalidomide-based therapy in myeloma with renal failure
Real world data: bortezomib-based therapy for R/R myeloma
Bortezomib-based triplet regimens in MM patients undergoing transplantation
GMMG-HD4 and MM5: bortezomib vs. lenalidomide for myeloma maintenance
Transplant vs bortezomib and LEN/DEX in multiple myeloma
Bendamustine-bortezomib-dexamethasone in R/R multiple myeloma
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
Better Proteasome Inhibitor-Based Therapy in MM - by Pete Voorhees, MD
Bortezomib and dexamethasone after ASCT for high-risk MM
Know Your Myeloma Therapy: What's Available for Maintenance Therapy?
The safety and efficacy of isatuximab, bortezomib, lenalidomide, and dexamethasone in NDMM
Bortezomib for the tr multiple myeloma, a type of cancer that affects plasma cells in bone marrow
